JACOBS LEVY EQUITY MANAGEMENT, INC - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 255 filers reported holding EDITAS MEDICINE INC in Q2 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q3 2023$648,149
+329.1%
83,096
+352.7%
0.00%
+300.0%
Q2 2023$151,053
+12.8%
18,354
+21.5%
0.00%0.0%
Q4 2022$133,964
-89.8%
15,103
-85.9%
0.00%
-90.0%
Q3 2022$1,311,000
-8.9%
107,138
+41.6%
0.01%0.0%
Q1 2022$1,439,000
-70.4%
75,659
+9.1%
0.01%
-76.7%
Q4 2020$4,862,000
+92.5%
69,345
-23.0%
0.04%
+65.4%
Q3 2020$2,526,000
-24.1%
90,020
-20.0%
0.03%
-27.8%
Q2 2020$3,328,000
+148.7%
112,494
+66.7%
0.04%
+111.8%
Q1 2020$1,338,000
+34.6%
67,471
+100.9%
0.02%
+70.0%
Q4 2019$994,00033,5770.01%
Other shareholders
EDITAS MEDICINE INC shareholders Q2 2022
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 54,615$4,897,0002.55%
Capital Impact Advisors, LLC 130,000$9,114,0002.24%
ARK Investment Management 10,125,564$709,903,0001.89%
Nikko Asset Management Americas, Inc. 4,388,143$307,653,0001.75%
Spectrum Planning & Advisory Services Inc. 17,522$1,228,0001.32%
DDD Partners, LLC 79,527$5,576,0001.10%
Brevan Howard Capital Management LP 76,420$5,358,0001.08%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 538,721$37,770,0000.75%
DC Investments Management, LLC 3,627$254,0000.63%
Haafor (Singapore) Pte. Ltd. 4,761$334,0000.62%
View complete list of EDITAS MEDICINE INC shareholders